Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Drug evaluation: DNA/MVA prime-boost HIV vaccine.

Kent S, De Rose R, Rollman E.

Curr Opin Investig Drugs. 2007 Feb;8(2):159-67. Review.

PMID:
17328232
2.

Development of a DNA-MVA/HIVA vaccine for Kenya.

Hanke T, McMichael AJ, Mwau M, Wee EG, Ceberej I, Patel S, Sutton J, Tomlinson M, Samuel RV.

Vaccine. 2002 May 6;20(15):1995-8. Review.

PMID:
11983261
3.

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.

Hanke T, Goonetilleke N, McMichael AJ, Dorrell L.

J Gen Virol. 2007 Jan;88(Pt 1):1-12. Review. Erratum in: J Gen Virol. 2008 Feb;89(Pt 2):609. Goonetilleke, Nilu [added].

PMID:
17170430
4.

Therapeutic and prophylactic DNA vaccines for HIV-1.

Ramirez LA, Arango T, Boyer J.

Expert Opin Biol Ther. 2013 Apr;13(4):563-73. doi: 10.1517/14712598.2013.758709. Review.

PMID:
23477730
5.

HIV vaccine development.

Watkins DI.

Top HIV Med. 2010 Apr-May;18(2):35-6. Review.

6.

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.

Gilbert SC, Moorthy VS, Andrews L, Pathan AA, McConkey SJ, Vuola JM, Keating SM, Berthoud T, Webster D, McShane H, Hill AV.

Vaccine. 2006 May 22;24(21):4554-61. Epub 2005 Aug 24. Review.

PMID:
16150517
7.

Technology evaluation: HIVAC-1e.

Zheng R.

Curr Opin Mol Ther. 1999 Feb;1(1):121-5. Review.

PMID:
11249677
8.

MVA as a vector for vaccines against HIV-1.

Im EJ, Hanke T.

Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S89-97. Review.

PMID:
15285708
9.

Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine.

Sealy R, Slobod KS, Flynn P, Branum K, Surman S, Jones B, Freiden P, Lockey T, Howlett N, Hurwitz JL.

Int Rev Immunol. 2009;28(1):49-68. doi: 10.1080/08830180802495605. Review.

10.

Nonreplicating vectors in HIV vaccines.

Johnson JA, Barouch DH, Baden LR.

Curr Opin HIV AIDS. 2013 Sep;8(5):412-20. doi: 10.1097/COH.0b013e328363d3b7. Review.

11.

Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines.

Boukhebza H, Bellon N, Limacher JM, Inchauspé G.

Hum Vaccin Immunother. 2012 Dec 1;8(12):1746-57. doi: 10.4161/hv.21689. Epub 2012 Aug 16. Review.

12.

Nano-Delivery Vehicles/Adjuvants for DNA Vaccination Against HIV.

Dong Y, Yang J, Zhang J, Zhang X.

J Nanosci Nanotechnol. 2016 Mar;16(3):2126-33. Review.

PMID:
27455611

Supplemental Content

Support Center